GILD
Insider TradingGilead Sciences
Health Care / Biotechnology
Recent Insider Transactions
Source: SEC Form 4 filings. Updated daily. Transaction codes: P = Open-Market Purchase, S = Open-Market Sale, F = Tax Withholding, A = Award, M = Option Exercise.
| Date | Reporter | Type | Shares | Price | Total Value |
|---|---|---|---|---|---|
| May 27, 2026 | GILEAD SCIENCES, INC. | AAward | 471,698 | $26.50 | $12.5M |
| May 18, 2026 | Mercier Johanna Chief Comm & Corp Aff Officer | MOption Exercise10b5-1 | 25,000 | $66.64 | $1.7M |
| May 18, 2026 | Dickinson Andrew D Chief Financial Officer | SOpen-Market Sale10b5-1 | 3,000 | $132.27 | $397K |
| May 4, 2026 | Horning Sandra | AAward | 1,146 | $0.00 | $0.00 |
| May 4, 2026 | Kramer Kelly A. | AAward | 6,030 | $0.00 | $0.00 |
| May 4, 2026 | WELTERS ANTHONY | AAward | 1,146 | $0.00 | $0.00 |
| May 4, 2026 | MANWANI HARISH | AAward | 1,146 | $0.00 | $0.00 |
| May 4, 2026 | Bluestone Jeffrey | AAward | 1,146 | $0.00 | $0.00 |
| May 4, 2026 | BARTON JACQUELINE K | AAward | 1,146 | $0.00 | $0.00 |
| May 4, 2026 | Rodriguez Javier | AAward | 1,146 | $0.00 | $0.00 |
| May 4, 2026 | LOVE TED W | AAward | 1,146 | $0.00 | $0.00 |
| Apr 29, 2026 | O'Day Daniel Patrick Chairman & CEO | SOpen-Market Sale10b5-1 | 10,000 | $129.16 | $1.3M |
| Apr 16, 2026 | Dickinson Andrew D Chief Financial Officer | SOpen-Market Sale10b5-1 | 3,000 | $140.96 | $423K |
| Apr 16, 2026 | Mercier Johanna Chief Comm & Corp Aff Officer | SOpen-Market Sale10b5-1 | 3,000 | $140.96 | $423K |
| Mar 30, 2026 | O'Day Daniel Patrick Chairman & CEO | SOpen-Market Sale10b5-1 | 10,000 | $136.82 | $1.4M |
| Mar 17, 2026 | Dickinson Andrew D Chief Financial Officer | SOpen-Market Sale10b5-1 | 3,000 | $144.23 | $433K |
| Mar 17, 2026 | Mercier Johanna Chief Comm & Corp Aff Officer | SOpen-Market Sale10b5-1 | 3,000 | $144.23 | $433K |
Get GILD insider alerts in your inbox
The Filing Cabinet tracks SEC Form 4 filings for every S&P 500 company and delivers a free daily digest of the most significant insider trades.